BNTC

Benitec Biopharma Inc.

Price

$11.71

return (12m)

6.84%

p/e

-13.62

p/bv

3.09

DIVIDEND YIELD

0.00%

BNTC price

Benitec Biopharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BNTC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-11.42%

3 months

-3.86%

1 year

6.84%

2 years

46.19%

5 years

-80.60%

10 years

-97.34%

Fundamentals BNTC

Valuation

P/E

-13.62

Sector -3.98

Industry -3.98

P/BV

3.09

Sector 2.00

Industry 2.00

P/Revenue (PSR)

Sector -4.41

Industry -4.41

EV/EBITDA

-28.30

Sector -245.01

Industry -245.01

EV/EBIT

-28.05

Sector -666.51

Industry -666.51

P/EBITDA

-12.26

Sector -4.07

Industry -4.07

P/EBIT

-12.14

Sector -4.24

Industry -4.24

P/Total Assets

3.03

Sector 1.40

Industry 1.40

P/Net Current Assets

3.10

Sector -11.65

Industry -11.65

P/Working Capital

3.10

Sector -10.95

Industry -10.95

EPS

-0.85

Sector -2.20

Industry -2.20

BVPS

3.74

Sector 1.95

Industry 1.95

Efficiency

Gross Margin

0.00%

Sector 36.05%

Industry 36.05%

EBITDA Margin

Sector -16,817.20%

Industry -16,817.20%

EBIT Margin

Sector -4,256,841.62%

Industry -4,256,841.62%

Operating Margin

0.00%

Sector -38.74%

Industry -38.74%

Net Profit Margins

0.00%

Sector -39.50%

Industry -39.50%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-22.66%

Sector -66.41%

Industry -66.41%

ROA

-22.21%

Sector -66.55%

Industry -66.55%

ROIC

-2,687.51%

Sector -1,703.97%

Industry -1,703.97%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

56.89

Sector 2.90

Industry 2.90

Net Debt / EBITDA

13.73

Sector -14.63

Industry -14.63

Net Debt / EBIT

13.61

Sector -7.24

Industry -7.24

Net Debt / Equity

-1.01

Sector -33,201.65

Industry -33,201.65

Gross Debt / Equity

0.00

Sector -0.02

Industry -0.02

Equity/Assets

0.98

Sector 0.42

Industry 0.42

Liabilities/Assets

0.02

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

18.51%

Sector -

Industry -

Fundamentals BNTC

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
BNTC	-13.62	3.09	-22.66%	0.00%	$565.71 M	0.00%
JNJ	29.40	7.28	24.76%	2.04%	$618.44 B	21.48%
PFE	18.75	1.55	8.29%	6.97%	$140.44 B	11.83%
ABBV	71.07	0.00	-%	2.66%	$448.43 B	9.80%
NVO	11.00	6.65	60.40%	3.96%	$208.75 B	37.15%
MRK	35.97	7.00	19.45%	2.58%	$321.35 B	13.59%
AZN	25.16	5.22	20.74%	1.89%	$262.79 B	17.02%
GILD	17.55	6.90	39.33%	2.47%	$161.73 B	30.99%
BMY	14.12	5.87	41.59%	3.91%	$131.06 B	18.87%
ZTS	12.23	10.00	81.75%	2.69%	$32.33 B	27.79%
REGN	17.58	2.40	13.65%	0.49%	$76.11 B	27.86%
HALO	27.82	44.19	158.82%	0.00%	$9.70 B	23.13%
AMGN	26.41	22.42	84.87%	2.57%	$206.02 B	20.96%
MCK	22.00	-125.59	-570.98%	0.38%	$104.74 B	1.18%
VRTX	27.75	6.22	22.41%	0.00%	$120.39 B	35.51%
CAH	34.61	-20.14	-58.20%	0.89%	$53.82 B	0.62%
HRMY	13.88	2.22	16.00%	0.00%	$2.02 B	16.20%
BIIB	36.30	1.61	4.43%	0.00%	$30.30 B	8.32%
MEDP	32.46	36.77	113.29%	0.00%	$15.95 B	17.67%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BNTC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	05/31/2018	06/08/2018	0.73950000

ABOUT Benitec Biopharma

Benitec Biopharma Inc.

Average Investor10 user rating

4.0 (1 people)

United States

7 years

Founded: 2019

2012

Time since IPO - 14 years

14

Employees

Benitec Biopharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $565.71 million, with shareholders equity totaling $183.33 million.

The company employs approximately 14 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Benitec Biopharma Inc. reported $- in revenue, generating net income of $-41.54 million.

Key financial metrics include a P/E ratio of -13.62, a price-to-book (P/B) ratio of 3.09, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BNTC.

Market cap

$565.71 million

Net worth

$183.33 million

$183,330,000.00

Assets

$187.00 million

$187,000,000.00

Total Shares Outstanding

49.00 million

49,000,000

Average Daily Trading Volume

$111.90 Thousand

$111,902.00

Sector

Health Care

Industry

Biotechnology

BNTC

BNTC revenue and profits

Financial Results BNTC

DRAG THE FRAME TO SEE MORE DATA

BNTC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$856.19 23,16% (12M)

P/E

22.00

0.38%

ROE

-570.98%

P/BV

-125.59

CAH - Cardinal Health

$230.03 49,01% (12M)

P/E

34.61

0.89%

ROE

-58.20%

P/BV

-20.14

JNJ - Johnson & Johnson

$256.35 57,85% (12M)

P/E

29.40

2.04%

ROE

24.76%

P/BV

7.28

ABBV - AbbVie

$250.94 33,78% (12M)

P/E

71.07

2.66%

ROE

P/BV

0.00

MRK - Merck & Co.

$130.20 70,76% (12M)

P/E

35.97

2.58%

ROE

19.45%

P/BV

7.00

AZN - AstraZeneca

$169.64 16,43% (12M)

P/E

25.16

1.89%

ROE

20.74%

P/BV

5.22

NVO - Novo Nordisk

$47.08 1,12% (12M)

P/E

11.00

3.96%

ROE

60.40%

P/BV

6.65

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$856.19 23,16% (12 M)

P/L

22.00

0.38%

ROE

-570.98%

P/VP

-125.59

CAH - Cardinal Health

$230.03 49,01% (12 M)

P/L

34.61

0.89%

ROE

-58.20%

P/VP

-20.14

JNJ - Johnson & Johnson

$256.35 57,85% (12 M)

P/L

29.40

2.04%

ROE

24.76%

P/VP

7.28

ABBV - AbbVie

$250.94 33,78% (12 M)

P/L

71.07

2.66%

ROE

P/VP

0.00

MRK - Merck & Co.

$130.20 70,76% (12 M)

P/L

35.97

2.58%

ROE

19.45%

P/VP

7.00

AZN - AstraZeneca

$169.64 16,43% (12 M)

P/L

25.16

1.89%

ROE

20.74%

P/VP

5.22

NVO - Novo Nordisk

$47.08 1,12% (12 M)

P/L

11.00

3.96%

ROE

60.40%

P/VP

6.65

Frequently Asked Questions

What is the price of Benitec Biopharma (BNTC) today?

A cotação de Benitec Biopharma (BNTC) hoje está em US$ 11.71, com uma variação de 6.84% em relação ao último ano. A cotação de Benitec Biopharma (BNTC) iniciou o ano negociando na casa dos US$ 13.47 e hoje está em US$ 11.71. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Benitec Biopharma (BNTC) e dados de ações do Ibovespa e mercados internacionais.

Quando Benitec Biopharma (BNTC) paga dividendos?

Benitec Biopharma (BNTC) não distribuiu dividendos no último ano.

Is Benitec Biopharma (BNTC) a good investment?

Atualmente, Benitec Biopharma (BNTC) está cotada a US$ 11.71, com um P/L de -13.62, representando um desvio de -970% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 6.84 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 6.84%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Benitec Biopharma (BNTC) stock?

Investir em ações de Benitec Biopharma (BNTC) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Benitec Biopharma (BNTC) yield today?

A rentabilidade de Benitec Biopharma (BNTC) foi de -11.42% no último mês, 6.84% no último ano e -80.60% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Benitec Biopharma (BNTC) hoje, o investimento total seria de US$ 1,171.00, com base na cotação atual de US$ 11.71.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,251.10
Em 5 anos: US$ 227.17
Em 10 anos: US$ 31.15

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BNTC

Benitec Biopharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BNTC

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT Benitec Biopharma

Benitec Biopharma Inc.

United States

7 years

2012

14

PROFIT X PRICE BNTC

Financial Results BNTC

BNTC cash flow

Asset, Revenue and Profit Growth - BNTC

BNTC balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

NVO - Novo Nordisk

Frequently Asked Questions